Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular and Molecular Biology 48: Signaling in Breast Cancer 1

ErbB2 activation of Notch1 signaling in breast cancer

Toshiyuki Sakamaki, Manran Liu, Sanjay Katiyar, Mahadev Rao, Shiguang Li, Yuzhi Yin, Luis E. Dettin, Richard G. Pestell and Robert I. Glazer
Toshiyuki Sakamaki
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manran Liu
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay Katiyar
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahadev Rao
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiguang Li
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuzhi Yin
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis E. Dettin
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard G. Pestell
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert I. Glazer
Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, NW Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2005
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 46, 2005

Abstract

3684

Notch signaling is evolutionarily conserved and plays a crucial role in regulating diverse cell fate decisions during development. Because malignant transformation is associated with an alteration in cell fate determination, changes in Notch signaling can potentially contribute to cancer development. The t(7:9)(q34;q34.4) translocation associated with T-cell leukemia encodes a constitutively active truncated Notch1 fragment, and gain-of-function mutations in Notch1 or Notch4 have been reported in breast cancer. In this study, we determined that Notch1 was constitutively active in invasive breast cancer and that Notch1 signaling interfaced with the initiation and maintenance of oncogenesis mediated by the ErbB2 signaling pathway, which is frequently activated in breast cancer. Constitutively active intracellular Notch1 was highly expressed in approximately 40% of invasive human breast cancers by tissue microarray analysis, and higher levels of activated Notch1 were also found in several breast cancer cell lines. In the latter instances, Notch activation was associated with either lower levels of Numb, a negative regulator or Notch, or with overexpression of ErbB2 and high levels of Musashi1, a negative regulator of Numb. Conditional expression of dominant-negative Notch1 in MDA-MB-231 cells inhibited growth and correlated with inhibition of Notch1-dependent transcription. Breast cancer cells expressing activated ErbB2/NeuT exhibited marked activation of Notch1-dependent reporter gene activity that was blocked by a selective ErbB2 antagonist, CP-654577. In addition, transformation of breast epithelial cells by NeuT was blocked by L-685,458, a γ-secretase inhibitor of Notch processing, which correlated with inhibition of Notch- and β-catenin/TCF-dependent reporter gene activity. These results suggest for the first that Notch1 is constitutively active in a high percentage of invasive breast cancers, and that Notch1 activity is linked to ErbB2 activation. These data provide a basis for determining whether inhibition of both ErbB2 activation and Notch processing may be an effective approach for breast cancer therapy.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 65 (9 Supplement)
May 2005
Volume 65, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ErbB2 activation of Notch1 signaling in breast cancer
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
ErbB2 activation of Notch1 signaling in breast cancer
Toshiyuki Sakamaki, Manran Liu, Sanjay Katiyar, Mahadev Rao, Shiguang Li, Yuzhi Yin, Luis E. Dettin, Richard G. Pestell and Robert I. Glazer
Cancer Res May 1 2005 (65) (9 Supplement) 869;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
ErbB2 activation of Notch1 signaling in breast cancer
Toshiyuki Sakamaki, Manran Liu, Sanjay Katiyar, Mahadev Rao, Shiguang Li, Yuzhi Yin, Luis E. Dettin, Richard G. Pestell and Robert I. Glazer
Cancer Res May 1 2005 (65) (9 Supplement) 869;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A bidirectional “αvβ3 Integrin-ERK1/ERK2 MAPK“ connection regulates the proliferation of heregulin (HRG)-overexpressing breast cancer cells
  • Correlation of ErbB activation status and clinical response in Herceptin treated breast cancer patients
  • Potential of growth factor signaling kinases/ERα crosstalk to undermine the effects of estrogen deprivation in vitro
Show more Cellular and Molecular Biology 48: Signaling in Breast Cancer 1
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement